San Donato Hospital
| Italien | Türkei | Österreich | |
| Strahlentherapie bei Darmkrebs | von $7,000 | von $7,000 | von $12,000 |
| Stereotaktische Radiochirurgie | von $25,000 | von $4,500 | von $17,000 |
| Kraniotomie | von $25,000 | von $5,650 | von $20,000 |
| Chemotherapie bei Brustkrebs | von $4,500 | von $1,200 | von $15,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Medulloblastom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Medulloblastom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Medulloblastom-Behandlungsreise nie allein.
Professor Pietro Mortini ist auf minimalinvasive Gehirn- und Wirbelsäulenchirurgie spezialisiert und nutzt Neuronavigation für Präzision und eine schnellere Genesung.
Italian hospitals utilize risk-stratified multimodal therapy following AIEOP and SIOP Europe guidelines. Treatment includes maximal safe surgical resection, craniospinal irradiation, and multi-agent chemotherapy. Protocols vary by age and molecular subgroup to ensure high survival rates while protecting neurological function.
Bookimed Expert Insight: Italian neurosurgery expertise is highly concentrated in specialized centers. Dr. Pietro Mortini at San Raffaele has over 30 years experience and holds a biological tissue regeneration patent. This depth of specialization often allows for more precise, minimally invasive brain operations than general oncological facilities.
Patient Consensus: Families emphasize finding dedicated pediatric neuro-oncology units rather than general teams. Patients note that second opinions are vital when deciding on radiation timing for younger children.
Molecular subgrouping and targeted therapies are available for medulloblastoma in Italy at certified oncology hubs. Italian centers utilize next-generation sequencing and DNA methylation profiling. These tools identify specific WNT, SHH, Group 3, or Group 4 subgroups. This data determines personalized treatment intensity and eligibility for clinical trials.
Bookimed Expert Insight: Italian neuro-oncology follows a hub-and-spoke model where smaller clinics often send samples to major centers. Data shows that clinics like Maria Cecilia Hospital or San Donato hold JCI or IRCCS accreditations. These credentials ensure they follow the World Health Organization classification for brain tumors. Patients should confirm if their chosen clinic has an internal molecular pathology lab. This can significantly speed up the start of subgroup-specific treatment.
Patient Consensus: Patients emphasize that a basic pathology report is no longer enough and often request next-generation sequencing early. Many note that while advanced testing is possible, it usually requires treatment at major university or pediatric specialty centers.
Proton beam therapy is a preferred alternative to conventional radiation for medulloblastoma in Italy, specifically for reducing long-term toxicities in children. While it provides similar survival rates, protons better spare healthy brain tissue. It is prioritized based on patient age, tumor location, and clinical eligibility.
Bookimed Expert Insight: While Italy has specialized hubs like CNAO, the referral process for medulloblastoma remains highly selective. Data shows leading Italian neurosurgeons, like Dr. Pietro Mortini at San Raffaele, focus heavily on multi-disciplinary approaches. This means proton therapy is rarely a standalone choice. It is often integrated with advanced neuronavigation or minimally invasive surgery at JCI-accredited facilities.
Patient Consensus: Patients note the most difficult part is obtaining a referral quickly enough to meet treatment timelines. Many emphasize asking the oncology team directly if proton therapy is medically indicated for their specific risk group.
Italy reports a 5-year survival rate for pediatric medulloblastoma between 70% and 85%. Adult cohorts achieve approximately 75% to 88% survival. Italian neuro-oncology centers follow SIOP Europe frameworks. The prognosis is stable with long-term survival rates often maintained within 4% after the 5-year mark.
Bookimed Expert Insight: Italian centers like San Donato Hospital and Maria Cecilia Hospital integrate neurosurgery with specialized oncology units. This multidisciplinary approach is why Italy ranks among Bookimed's top 10 countries globally for complex medical care. Patients benefit from surgeons like Professor Pietro Mortini who hold international teaching credentials and patents in tissue regeneration. These advanced individual expertises often lead to higher precision during craniotomies and minimally invasive brain operations.
Top Italian hospitals for medulloblastoma include Ospedale Pediatrico Bambino Gesù and Maria Cecilia Hospital. These centers utilize advanced neuro-oncology protocols and precision microsurgery. Treatment often combines surgical resection with specialized radiation therapy to ensure optimal long-term neurocognitive outcomes for patients.
Bookimed Expert Insight: Maria Cecilia Hospital in Bologna is a strategic choice for complex brain tumor cases. While many focus on Rome, this JCI-accredited facility handles over 1,000 advanced cranial cases annually. Their high volume correlates with refined surgical expertise in delicate areas near the brainstem.
Patient Consensus: Patients emphasize finding a hospital that manages the entire pathway from molecular subtyping to specialized rehabilitation. Many note that specialized children's centers are preferable over adult hospitals for pediatric cases to ensure proper long-term follow-up.
Non-EU medical tourists entering Italy for medulloblastoma treatment require a Medical Treatment Visa (Visto per Cure Mediche). Essential documents include a formal hospital invitation, certified medical translations, and proof of a 30% treatment deposit. Patients must also secure a residence permit within 8 days of arrival.
Bookimed Expert Insight: While many focus on the visa, the real bottleneck is often hospital response time. Clinics like Maria Cecilia Hospital handle high neurosurgery volumes but require complete dossiers for review. Providing digital imaging via cloud links alongside translated reports can speed up your official invitation letter.
Patient Consensus: Patients emphasize keeping all diagnostic scans on a USB drive for immediate review. They note that having a treatment-specific acceptance letter instead of a basic appointment note makes the visa process much smoother.
Italian pediatric oncology centers provide language support and specialized family services for international medulloblastoma patients. Facilities like Bambino Gesù and Gaslini use international patient offices to manage cultural mediation and 24/7 translation. These services cover neurosurgery, chemotherapy, and long-term logistical support for families.
Bookimed Expert Insight: Italian neurosurgery centers often integrate research directly with clinical care. For example, Professor Dr. Pietro Mortini at San Raffaele leads experimental neurosurgery units. Our data shows that top-rated clinics like Maria Cecilia Hospital prioritize international accessibility. This facility is located near international airports and provides dedicated patient transfer services.
Patient Consensus: Parents note that hospital staff often allow one parent to stay overnight. Patients emphasize arranging accommodation early through the hospital international office or local charity networks.